Cingulate_Logo_400x400_twitter.jpg
Cingulate to Host CNS Key Opinion Leader Panel in New York City
October 17, 2023 14:22 ET | Cingulate Inc.
KANSAS CITY, Kan., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
MDbio_Logo.png
Groundbreaking Study Finds Natural Formulation by MDbio – The Doctors BrandTM Significantly Improves Sleep, Anxiety, Stress, and Overall Well-being
October 03, 2023 09:00 ET | MDbio
Los Angeles, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In a momentous large-scale clinical trial, a MDSleep formulation by MDbio – The Doctors BrandTM was proven to significantly improve sleep compared...
Lifeist.png
Lifeist's Mikra Introduces Innovative New Mental Health Product and Provides Corporate Update
September 26, 2023 07:00 ET | Lifeist Wellness Inc.
TORONTO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Inc. to Present at the LD Micro Main Event XVI
September 21, 2023 13:30 ET | Cingulate Inc.
KANSAS CITY, Kan., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
logo.png
Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA
September 20, 2023 08:28 ET | Silo Pharma, Inc.
Pre-IND submission to FDA targeted for first quarter 2024 Silo partners with Kymanox for SPC-15 ENGLEWOOD CLIFFS, NJ, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq:...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Inc. Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
August 14, 2023 16:15 ET | Cingulate Inc.
Werth Family Investment Associates Provides Additional Capital InvestmentPhase 3 Adult Efficacy and Safety Trial of CTx-1301 Data ReleasedCTx-1301 Phase 3 Pediatric and Adolescent Studies Underway ...
ihl_logo.png
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
July 28, 2023 07:30 ET | Incannex Healthcare
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is...
MDbio_Logo.png
MDbio – The Doctors BrandTM Publishes New Article About Artificial Intelligence in Healthcare
July 24, 2023 09:00 ET | MDbio Wellness
Beverly Hills, California, July 24, 2023 (GLOBE NEWSWIRE) --  MDbio – The Doctors BrandTM published a new article about artificial intelligence in healthcare and what the future of this industry...
Global Online Therapy Services Market
North America Leads Global Online Therapy Services Market in 2022, Asia-Pacific to Witness Rapid Growth, According to New Report
July 21, 2023 05:43 ET | Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Online Therapy Services Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This comprehensive report provides...
22157.jpg
The Future of Global Mental Health Management Research Report 2023: Complementing Prescription Therapies with AI/ML/VR for Better Outcomes to Become More Prominent
July 20, 2023 05:38 ET | Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "The Future of Mental Health Management" report has been added to ResearchAndMarkets.com's offering. This report identifies the challenges, drivers,...